Loading provider…
Loading provider…
Hematology & Oncology Physician in Staten Island, NY
NPI: 1154313542Primary Practice Location
STATEN ISLAND UNIVERSITY HOSPITAL
475 Seaview Ave, Staten Island, NY
Primary Employer
Northwell Health Center for Advance Medicine
cancer.northwell.edu
HQ Phone
Get MD Qun's Phone Numberphone_androidMobile
Get MD Qun's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Nanjing University Of Traditional Chinese Medicine
Medical School
Until 1983
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 229 | 469 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 143 | 179 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 71 | 72 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 39 | 124 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 32 | 64 |
Authors: Hildebrandt, Ellen, Zhang, Qinghai, Cant, Natasha, Ding, Haitao, Dai, Qun, Peng, Lingling, Fu, Yu, DeLucas, Lawrence J, Ford, Robert, Kappes, John C, Urbatsch, Ina L
Journal: Biochim Biophys Acta
Publication Date: 2014-07-24
Acute promyelocytic leukaemia (APL) in a patient with Crohn's disease and exposure to infliximab: a rare clinical presentation and review of the literature.
Authors: Abhirami Vivekanandarajah
Publication Date: 2014-05-21
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, OTHER: Patient Observation
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Capecitabine
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, DRUG: Exemestane, DRUG: Entinostat, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, DRUG: Goserelin Acetate, DRUG: Goserelin